Literature DB >> 8688713

Anabolic steroid abuse by body builders and male subfertility.

F H Lloyd1, P Powell, A P Murdoch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8688713      PMCID： PMC2351471          DOI： 10.1136/bmj.313.7049.100

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Anabolic steroid-induced hypogonadotropic hypogonadism.

Authors:  J P Jarow; L I Lipshultz
Journal:  Am J Sports Med       Date:  1990 Jul-Aug       Impact factor: 6.202

2.  Adenocarcinoma of prostate in 40-year-old body-builder.

Authors:  J T Roberts; D M Essenhigh
Journal:  Lancet       Date:  1986-09-27       Impact factor: 79.321

3.  The reversibility of anabolic steroid-induced azoospermia.

Authors:  P J Turek; R H Williams; J H Gilbaugh; L I Lipshultz
Journal:  J Urol       Date:  1995-05       Impact factor: 7.450

4.  Anabolic steroids and semen parameters in bodybuilders.

Authors:  U A Knuth; H Maniera; E Nieschlag
Journal:  Fertil Steril       Date:  1989-12       Impact factor: 7.329

Review 5.  Current perspectives on anabolic-androgenic steroid abuse.

Authors:  S E Lukas
Journal:  Trends Pharmacol Sci       Date:  1993-02       Impact factor: 14.819

6.  Reversible azoospermia induced by the anabolic steroid 19-nortestosterone.

Authors:  T Schürmeyer; U A Knuth; L Belkien; E Nieschlag
Journal:  Lancet       Date:  1984-02-25       Impact factor: 79.321

7.  Dying to be big: a review of anabolic steroid use.

Authors:  H M Perry; D Wright; B N Littlepage
Journal:  Br J Sports Med       Date:  1992-12       Impact factor: 13.800
  7 in total
  7 in total

1.  Gym and tonic: a profile of 100 male steroid users.

Authors:  N A Evans
Journal:  Br J Sports Med       Date:  1997-03       Impact factor: 13.800

2.  Use of anabolic steroids has been reported by 9% of men attending gymnasiums.

Authors:  P Korkia
Journal:  BMJ       Date:  1996-10-19

3.  Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.

Authors:  Gen Kanayama; James I Hudson; James DeLuca; Stephanie Isaacs; Aaron Baggish; Rory Weiner; Shalender Bhasin; Harrison G Pope
Journal:  Addiction       Date:  2015-02-25       Impact factor: 6.526

4.  The Safety of Human Chorionic Gonadotropin Monotherapy Among Men With Previous Exogenous Testosterone Use.

Authors:  Quinn Rainer; Raghav Pai; Isaac Zucker; Ranjith Ramasamy; Thomas A Masterson
Journal:  Cureus       Date:  2022-06-10

Review 5.  Androgens and male fertility.

Authors:  G R Dohle; M Smit; R F A Weber
Journal:  World J Urol       Date:  2003-10-18       Impact factor: 4.226

Review 6.  Anabolic steroid use: patterns of use and detection of doping.

Authors:  Michael R Graham; Bruce Davies; Fergal M Grace; Andrew Kicman; Julien S Baker
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

7.  Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study.

Authors:  Jon Jarløv Rasmussen; Christian Selmer; Peter Busch Østergren; Karen Boje Pedersen; Morten Schou; Finn Gustafsson; Jens Faber; Anders Juul; Caroline Kistorp
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.